SIRT1 contributes to neuroendocrine differentiation of prostate cancer

被引:24
|
作者
Ruan, Lin [1 ,2 ]
Wang, Lei [3 ]
Wang, Xiaosong [1 ,4 ]
He, Ming [1 ,4 ]
Yao, Xiaoguang [1 ,4 ]
机构
[1] Hebei Univ Chinese Med, Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Nephrol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Dept Urol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Univ Chinese Med, Coll Integrat Med, Shijiazhuang, Hebei, Peoples R China
关键词
prostate cancer; SIRT1; neuroendocrine; N-Myc; Akt; OXIDATIVE STRESS; CELL-SURVIVAL; RESISTANT; EXPRESSION; P53; PROMOTES; MODULATION; APOPTOSIS; AUTOPHAGY; GENOMICS;
D O I
10.18632/oncotarget.23111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epigenetic factor SIRT1 can promote prostate cancer progression, but it is unclear whether SIRT1 contributes to neuroendocrine differentiation. In this study, we showed that androgen deprivation can induce reactive oxygen species production and that reactive oxygen species, in turn, activate SIRT1 expression. The increased SIRT1 expression induces neuroendocrine differentiation of prostate cancer cells by activating the Akt pathway. In addition, the interaction between Akt and SIRT1 is independent of N-Myc and can drive the development of neuroendocrine prostate cancer when N-Myc is blocked. Furthermore, SIRT1 facilitates tumor maintenance, and targeting SIRT1 may reduce the tumor burden during androgen deprivation. Our findings suggest that SIRT1 is a potential target for therapeutic intervention.
引用
下载
收藏
页码:2002 / 2016
页数:15
相关论文
共 50 条
  • [31] MUC1 induces neuroendocrine differentiation of prostate cancer
    Yasumizu, Yota
    Kosaka, Takeo
    Hongo, Hiroshi
    Oya, Mototsugu
    CANCER SCIENCE, 2022, 113 : 1595 - 1595
  • [32] FOXA1 inhibits prostate cancer neuroendocrine differentiation
    J Kim
    H Jin
    J C Zhao
    Y A Yang
    Y Li
    X Yang
    X Dong
    J Yu
    Oncogene, 2017, 36 : 4072 - 4080
  • [33] FOXA1 inhibits prostate cancer neuroendocrine differentiation
    Kim, J.
    Jin, H.
    Zhao, J. C.
    Yang, Y. A.
    Li, Y.
    Yang, X.
    Dong, X.
    Yu, J.
    ONCOGENE, 2017, 36 (28) : 4072 - 4080
  • [34] SIRT1 in Secretory Organ Cancer
    Frazzi, Raffaele
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [35] Sirt1 transgenic and cancer models
    Serrano, Manuel
    CANCER RESEARCH, 2011, 71
  • [36] SIRT1 Expression and Colon Cancer
    Smith, M. H.
    Pruitt, W.
    Pruitt, K.
    Meschonat, C.
    Grand, R.
    Chu, Q.
    Li, B.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 86 - 86
  • [37] SIRT1: roles in aging and cancer
    Kim, Eun-Joo
    Um, Soo-Jong
    BMB REPORTS, 2008, 41 (11) : 751 - 756
  • [38] APC MUTATION CONTRIBUTES TO NEUROENDOCRINE DIFFERENTIATION AND POOR OVERALL SURVIVAL IN METASTATIC PROSTATE CANCER PATIENTS
    Baba, Yuto
    Kosaka, Takeo
    Nakamura, Kohei
    Yasumizu, Yota
    Tanaka, Nobuyuki
    Takeda, Toshikazu
    Matsumoto, Kazuhiro
    Morita, Shinya
    Mizuno, Ryuichi
    Nishihara, Hiroshi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2023, 209 : E383 - E383
  • [39] Expression Patterns of ERα, ERβ, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue
    Choi, Jae Hwi
    Choi, See Min
    Lee, Sin Woo
    Jeh, Seong Uk
    Hyun, Jae Seog
    Lee, Min Ho
    Lee, Chunwoo
    Kam, Sung Chul
    Kim, Dong Chul
    Lee, Jong Sil
    Hwa, Jeong Seok
    ANTICANCER RESEARCH, 2021, 41 (03) : 1377 - 1386
  • [40] Functions of histone deacetylase SIRT1 in neural differentiation
    Hisahara, Shin
    Chiba, Susumu
    Matsumoto, Hiroyuki
    Horio, Yoshiyuki
    NEUROSCIENCE RESEARCH, 2006, 55 : S144 - S144